AMD’s still trading a box between 200–205 and 228–230. We’re camped in the upper half (~223–224), which is where breakouts ...

An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation's PRIMA implant is the first treatment in clinical trials to successfully restore functional ...

AMD is using CES 2026 as a launch vehicle to add several of its popular Ryzen AI Max+ and Ryzen 9000 X3D processors to its stack, but the real story might be the performance improvements AMD is ...

Advanced Micro Devices (AMD) has been on an extraordinary run lately, with shares soaring 116%, in the past nine months, as enthusiasm around AI hardware continues to reshape the semiconductor ...

For the first time, a vision-restoration effort has achieved successful outcomes in a significant number of patients. Clinical trial findings recently published in the New England Journal of Medicine ...

The MarketWatch News Department was not involved in the creation of this content. SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- STRADVISION, a global leader in AI-based vision perception ...

Forward-looking: AMD has revealed a new CPU roadmap that looks back to Zen 4 and stretches all the way to its future Zen 7 architecture. The slide also confirms some details about Zen 6, including the ...

SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- STRADVISION, a global leader in AI-based vision perception technology, today announced a multi-year collaboration with AMD to redefine the future of ...

AMD is a distant second to Nvidia in the data center GPU space. In recent quarters, the company's products are starting to gain serious traction. If AMD keeps its momentum going, it could become a ...

Age-related macular degeneration (AMD) is a common eye condition in older adults that can affect central vision. Geographic atrophy is an advanced form of AMD that causes permanent vision changes.

This is a quickly progressing field, according to Sarju Patel, MD, attending physician at Retinal Consultants of America. He has high expectations that advances from subtly tinted eyeglass lenses to ...

"The goal of treating macular degeneration is to keep as much vision as possible," notes Sarju Patel, MD, attending physician at Retinal Consultants of America. Referring patients to low-vision ...